Search Results 1351-1360 of 38432 for Two-phase

  1. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide Plus Pembrolizumab In Newly Diagnosed Glioblastoma - Mayo Clinic

    This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune® (Tumor Treating Fields at 200 kHz) together with maintenance ...

  2. Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression (ADVANCE Trial) - Mayo Clinic

    Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. Inpatient Psychiatric Units in Minnesota - Overview - Mayo Clinic

    Phase 2: Intensive Outpatient Program. Participants engage in mindfulness ... Based on need and collaborative understanding of presenting concerns, patients can ...

  4. A Study of Selpercatinib to Treat Participants with RET-Mutant Medullary Thyroid Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. A Study Of Pirtobrutinib In Participants With Immune Thrombocytopenia - Mayo Clinic

    The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be administered ...

  6. Laryngeal (Voice Box) Cancer Clinical Trials - Mayo Clinic Research

    ... Phase 2 dose (RP2D). BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell ...

  7. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with capecitabine ...

  8. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

    This is a Phase 2, multi-center, dose-ranging, randomized, double-blind study of TERN-601 in non-diabetic adults with overweight or obesity. Treatment with ...

  9. Primary sclerosing cholangitis (PSC) - Symptoms and causes - Mayo Clinic

    May 10, 2025. Related. Associated Procedures. Liver biopsy · Liver function tests · Liver transplant · MELD (model for end-stage liver disease) score · MRI.

  10. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    The primary objectives of the study are to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of H3B-8800 administered orally in ...